Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00284388
First received: January 30, 2006
Last updated: February 13, 2009
Last verified: February 2009
  Purpose

Development of a non-invasive method for the determination of the position of optimal muscle length in the different muscles of the shoulder.

Analysis of the adaptation of the muscle to a new optimal length in patients with a shoulder prosthesis.


Condition Intervention
Shoulder Prosthesis
Procedure: Simultaneous controlled power measurement
Procedure: Surface EMG measurement

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Measurement of the optimal length of the muscles of the shoulder

Estimated Enrollment: 20
  Eligibility

Ages Eligible for Study:   40 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Shoulder prosthesis

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00284388

Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Rene Verdonk, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: René Verdonk, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00284388     History of Changes
Other Study ID Numbers: 2004/056
Study First Received: January 30, 2006
Last Updated: February 13, 2009
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on July 24, 2014